Key result
Frailty was independently associated with higher long-term all-cause mortality compared to non-frail patients (85.9% vs 53.8%; HR 2.06; 95% CI 1.51-2.81; P<0.001).
Why the study?
Does frailty predict long-term all-cause mortality in elderly patients hospitalized for NSTEMI?
Population
307 patients aged 75 years or older hospitalised for non-ST-segment elevation myocardial infarction
Comparison
Frail status vs Non-frail status
Design
Cohort
Follow-up
median 6.7 years
Authors
Loading...
May aid risk stratification; leaves open whether frailty interventions improve survival in cardiac cohorts.
Observational (n=307)
Yes
Does frailty predict long-term all-cause mortality in elderly patients hospitalized for NSTEMI?
Hazard Ratio: 2.06 (95% CI 1.51–2.81)
Absolute Event Rate: 85.9% vs 53.8%
p-value: p=< 0.001
Frailty is a strong, independent predictor of long-term all-cause mortality in elderly patients hospitalized for NSTEMI, highlighting its utility alongside comorbidity indices for risk stratification.
Ekerstad et al. (2018) conducted an observational in non-ST-segment elevation myocardial infarction (n=307). Frailty vs. Non-frail was evaluated on all-cause mortality (HR 2.06, 95% CI 1.51-2.81, p=< 0.001). Frailty was independently associated with higher long-term all-cause mortality compared to non-frail patients (85.9% vs 53.8%; HR 2.06; 95% CI 1.51-2.81; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: